TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
23 hedge funds and large institutions have $3.03M invested in Turnstone Biologics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
4
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$75K |
| 2 |
DAM
Deltec Asset Management
New York
|
+$38.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.4K |
| 4 |
GS
GTS Securities
New York
|
+$16.2K |
| 5 |
HF
HRT Financial
New York
|
+$15.7K |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$382K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$321K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$155K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$22.3K |
| 5 |
Millennium Management
New York
|
-$15.9K |